Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.0%
    Check dated 2024-09-04T05:13:10.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Recent updates clarify eligibility criteria for clinical trial participants, specifying that Phase I patients must have evaluable disease, while Phase II patients must have measurable disease as per RECIST 1.1, and outline restrictions on autoimmune disease treatments.
    Difference
    2%
    Check dated 2024-08-28T02:41:51.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-08-13T23:33:41.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.10.0, adding 12 more conditions and noting that the study now has 5 locations, while the previous version v2.9.7 has been removed.
    Difference
    0.3%
    Check dated 2024-07-23T14:49:54.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T08:44:18.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.
    Difference
    0.0%
    Check dated 2024-07-02T14:42:44.000Z thumbnail image

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.